MakeMyTrip completes upsized equity & convertible notes offerings worth billions
Rhea-AI Filing Summary
MakeMyTrip Limited (MMYT) filed a Form 6-K disclosing the completion of two capital-raising transactions on 23 June 2025:
- Primary Equity Offering: the company issued 16,000,000 ordinary shares, par value US$0.0005, at US$90 per share. Underwriters exercised their option in full to purchase an additional 2,400,000 shares, bringing the total shares sold to 18,400,000.
- Convertible Notes Offering: MakeMyTrip issued 0.00% convertible senior notes due 2030 with an aggregate principal amount of US$1.25 billion. Initial purchasers also exercised their option in full, adding another US$187.5 million, for a total principal amount of US$1.4375 billion.
Both offerings were upsized, and the overallotment options were fully exercised, indicating robust demand. The equity issuance was conducted through an underwritten registered public offering, while the notes were privately placed with qualified institutional buyers under Rule 144A. Press releases detailing each closing are attached as Exhibits 99.1 and 99.2.
No use-of-proceeds, pricing premium, or conversion terms were included in this filing. The transactions materially increase the company’s cash position but introduce potential share dilution from the new equity and future dilution from the convertible notes’ conversion.
Positive
- Robust demand: both underwriters and initial purchasers exercised full overallotment options, indicating strong investor appetite.
- Strengthened liquidity: sizeable proceeds from equity and convertible offerings improve the company’s cash position without immediate interest expense due to 0% notes.
Negative
- Share dilution: issuance of 18.4 million new ordinary shares directly reduces existing shareholders’ ownership percentage.
- Future dilution risk: 0% convertible notes due 2030 may convert into equity, potentially further diluting EPS and voting power.
Insights
TL;DR – MMYT raises >US$1.4 bn notes and 18.4 m shares; cash up, dilution risk.
The full exercise of overallotment options in both the equity and convertible note offerings signals strong institutional appetite. The 0% coupon lowers cash interest burden, and the staggered 2030 maturity gives balance-sheet flexibility. However, issuing 18.4 million shares at US$90 immediately dilutes existing shareholders, and future conversion of the notes could amplify dilution depending on the conversion price. Because no proceeds allocation was announced, investors cannot yet gauge return on this capital. Net, the deals are liquidity-enhancing but only moderately positive until capital deployment details emerge.
TL;DR – Large twin offerings add liquidity but heighten dilution overhang; risk tilted negative.
The simultaneous equity and convertible raises exceed US$2.8 billion in aggregate securities issued, a sizeable proportion for MMYT’s market cap. Immediate share count expansion reduces per-share metrics, and zero-coupon converts imply a likely in-the-money conversion structure that can pressure future EPS. Absent guidance on strategic use, the market may treat the financing as defensive rather than growth-oriented. Consequently, I view the disclosure as modestly negative for near-term equity valuation.
FAQ
How many new shares did MakeMyTrip (MMYT) issue in the June 2025 equity offering?
What was the offering price of MMYT’s primary equity issuance?
What is the principal amount of the 0.00% convertible senior notes issued by MakeMyTrip?
When do the newly issued convertible senior notes mature?
Were the overallotment options exercised in both offerings?
Under which rule were the convertible notes offered?
